Alurar rigakafin Corona tana ganin haske kuma an tabbatar da sakamakon

Kamfanonin harhada magunguna na Amurka biyu “Pfizer” da Kimiyyar Halittar Halitta ta Jamus “Biontech” sun rattaba hannu kan wata kwangilar da ta kai dala biliyan 1.95 tare da gwamnatin Amurka don samar da alluran rigakafi miliyan 100 na rigakafin cutar sankara mai yaduwa (Covid-19), kuma sun cimma yarjejeniya tare da samar da kayayyaki. Tarayyar Turai da Masarautar Saudiyya.Amurka, Kanada da Japan.

Shugaban Pfizer Albert Burla ya ce: "Yau babbar rana ce ga kimiyya da bil'adama, mun kai ga wannan muhimmin ci gaba a shirinmu na bunkasa rigakafin rigakafi a daidai lokacin da duniya ke matukar bukatarsa, tare da adadin kamuwa da cuta ya kafa sabbin bayanai, asibitocin da ke kusa da cikawa." da kuma tattalin arzikin da ke gwagwarmayar sake budewa."

Shugaban Kamfanin Biontech, Ugur Sahin, ya tabbatar wa kamfanin dillancin labarai na Reuters cewa yana da kwarin gwiwar cewa tasirin rigakafin rigakafin zai dauki tsawon shekara guda, duk da cewa ba a tabbatar da hakan ba.

Kamfanonin biyu sun yi tsammanin za su kera allurai miliyan 50 na alluran rigakafin a duniya a cikin wannan shekarar ta 2020, da kuma allurai biliyan 1.3 a shekarar 2021.

Kuma kamfanonin "Pfizer" da "Biontech" sun sanar a yau cewa gwajin gwajin da suka yi na rigakafin cutar Corona (Covid-19) da ke tasowa ya fi kashi 90 cikin XNUMX wajen kare cutar, kuma kamfanonin biyu sun ce har yanzu ba su samu ba. damuwa mai tsanani da kuma tsammanin tsaro A wannan watan, Amurka ta sami izinin Amurka don amfani da maganin a cikin yanayin gaggawa.

Bisa sakamakon farko da aka yi, an samu kariya daga kamuwa da kwayar cutar a cikin wadanda aka yi wa allurar, kwanaki bakwai bayan karbar kashi na biyu da kuma kwanaki 28 bayan karbar maganin farko.